Precision BioSciences
DTIL
115 hedge funds and large institutions have $211M invested in Precision BioSciences in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 23 reducing their positions, and 16 closing their positions.
113% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 23
38% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 16
33% more capital invested
Capital invested by funds: $159M → $211M (+$52M)
6% more funds holding
Funds holding: 109 → 115 (+6)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.07% less ownership
Funds ownership: 1.7% → 1.63% (-0.07%)
46% less call options, than puts
Call options by funds: $412K | Put options by funds: $769K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.26M |
| 2 |
Millennium Management
New York
|
+$3.84M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.34M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.84M |
| 5 |
SCM
Sio Capital Management
New York
|
+$1.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.91M |
| 2 |
VP
venBio Partners
San Francisco,
California
|
-$8.88M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$7.14M |
| 4 |
B
Bailard
Foster City,
California
|
-$1.67M |
| 5 |
JP Morgan Chase
New York
|
-$1.13M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CFG
126
Citizens Financial Group
Providence,
Rhode Island
| – | -$3K | -17 | Closed |
|
|
MAM
127
Meeder Asset Management
Dublin,
Ohio
| – | -$3K | -14 | Closed |
|
|
ASN
128
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -8 | Closed |
|
|
LC
129
Lindbrook Capital
Calabasas,
California
| – | -$1K | -6 | Closed |
|
130
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | +$219 | +1 | New |
|
DTIL Hedge Fund Activity: Q2 2020 in Review
115 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2020, worth a combined $211M — up 33% from $159M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new DTIL positions and 16 closed out — a net gain of 6 holders — while 49 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock, adding an estimated $5.26M. The largest seller was Fidelity Investments, cutting an estimated $8.91M.
- 115 institutional investors held Precision BioSciences (DTIL) as of Q2 2020, up from 109 in Q1 2020.
- Funds reported $211M of Precision BioSciences stock for Q2 2020, up 33% quarter-over-quarter.
- 22 funds opened new Precision BioSciences positions in Q2 2020 and 16 closed out, a net change of +6 holders.
- The largest Precision BioSciences buyer in Q2 2020 was BlackRock, an estimated $5.26M added.
- The largest Precision BioSciences seller in Q2 2020 was Fidelity Investments, an estimated $8.91M sold.
Based on aggregated 13F filings for Q2 2020.